Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR)

INTRODUCTION: Bloodstream infection (BSI) due to extended-spectrum β-lactamase-producing Gram-negative bacilli (ESBL-GNB) is increasing at an alarming pace worldwide. Although β-lactam/β-lactamase inhibitor (BLBLI) combinations have been suggested as an alternative to carbapenems for the treatment o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Gudiol, C, Royo-Cebrecos, C, Tebe, C, Abdala, E, Akova, M, Álvarez, R, Maestro-de la Calle, G, Cano, A, Cervera, C, Clemente, W T, Martín-Dávila, P, Freifeld, A, Gómez, L, Gottlieb, T, Gurguí, M, Herrera, F, Manzur, A, Maschmeyer, G, Meije, Y, Montejo, M, Peghin, M, Rodríguez-Baño, J, Ruiz-Camps, I, Sukiennik, T C, Carratalà, J
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2017
Matèries:
Infectious Diseases
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278288/
https://ncbi.nlm.nih.gov/pubmed/28115333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-013268
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars